The DTCC Consortium: Creating and Phenotyping Knockout Mouse Mutants
May 1, 2012 - Funded by the NIH as part of the second phase of the Knockout Mouse Project (KOMP2), the DTCC Consortium is creating a repository of knockout mouse lines and phenotype data as part of an international effort to help researchers develop better models of human disease. The University of California, Davis (UC Davis), Toronto Centre for Phenogenomics (TCP), Children’s Hospital Oakland Research Institute (CHORI) and Charles River have come together to form the DTCC Consortium. In addition to the DTCC Consortium, the other KOMP2 participants include The Jackson Laboratory as well as the collaboration of Baylor College of Medicine, the Wellcome Trust Sanger Institute and the Medical Research Council (MRC) Harwell.
Click here to learn how the DTCC Consortium supports the KOMP2 through production and phenotyping of mutant mouse lines.
Strengthen Your Research with the DTCC Consortium The DTCC Consortium is committed to providing the models and tools needed to further your research goals beyond the KOMP2 initiative. In collaboration with your internal scientific development team, the DTCC Consortium can provide additional breadth and depth to your model analysis to determine the suitability of a model or target to meet your specific research needs in multiple therapeutic areas. The DTCC Consortium offers access to the phenotyping platform used on the mutant mouse models as well as additional specialized phenotyping platforms at our facilities, including:
The DTCC can also assist in accessing models developed at the other International Mouse Phenotyping Consortium (IMPC) centers whose primary phenotyping results reveal phenotypes of interest to your scientific development team. In addition, our frozen and fixed tissue bank is available for collaborative and follow-up evaluation.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
Our study, presented at the 2013 Experimental Biology Conference, focuses on the phenotype and genotype comparison for C57BL/6N substrains contributing to the International Mouse Phenotyping Consortium (IMPC).
Clinical pathology data can assist you in selecting the most appropriate model for your study and can provide important information on the physiology and health of your research animals.
Jun 21–Jun 25
This five-day meeting draws diverse professionals from around the world to share their breakthroughs in the prevention, diagnosis and treatment of diabetes.
Jun 28–Jun 28
Charles River offers a wide range of seminars, workshops and training courses for animal technicians, veterinarians, biologists and laboratory technicians who work with laboratory animals. For more information about our course on animal health monitoring, click "view more" below.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.